Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(6)
BIOLOGICAL(4)
DRUG(2)
laboratory biomarker analysis
2 trials
phase_1phase_1_2
sumithira-vasu
decitabine
1 trial
phase_1
sumithira-vasu
Daratumumab
1 trial
phase_1_2
sumithira-vasu
Donor Lymphocyte Infusion
1 trial
phase_1_2
sumithira-vasu
Membrane-bound Interleukin-21-Expanded Haploidentical Natural Killer Cells
1 trial
phase_1
sumithira-vasu
aldesleukin
1 trial
phase_1
sumithira-vasu
Allogeneic Cytomegalovirus-Specific Cytotoxic T lymphocytes
1 trial
early_phase_1
sumithira-vasu
Allogeneic Adenovirus-specific Cytotoxic T Lymphocytes
1 trial
early_phase_1
sumithira-vasu

+3 more interventions

11 unique interventions3 categories

Analytics

Trial Phases

Phase 13
Phase 21

Trial Status

Completed2
Recruiting1
Terminated1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT03665675Early Phase 1Recruiting
Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
AdenovirusAllogeneic Hematopoietic Stem Cell Transplantation RecipientCytomegalovirus+2 more
PrincipalinvestigatorStart date: 2020-11-07
NCT04220684Phase 1Completed
Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML
Allogeneic Stem Cell Transplant RecipientBlasts 10 Percent or More of Bone Marrow Nucleated CellsRecurrent Acute Myeloid Leukemia+1 more
PrincipalinvestigatorStart date: 2020-06-11
NCT03537599Phase 1/2Terminated
Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant
Minimal Residual DiseaseRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related ChangesRecurrent Adult Acute Myeloid Leukemia+1 more
PrincipalinvestigatorStart date: 2020-01-10
NCT02316964Phase 1Completed
Decitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more
PrincipalinvestigatorStart date: 2015-04-21

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+7 more
Similarity Score15%

Farhad Ravandi-Kashani

M.D. Anderson Cancer Center

Related
7 trials

Shared therapeutic areas:

Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+6 more
Similarity Score14%

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
12 trials

Shared therapeutic areas:

Recurrent Adult Acute Myeloid LeukemiaRecurrent Childhood Acute Myeloid LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+6 more
Similarity Score14%

Leona Holmberg

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
7 trials

Shared therapeutic areas:

Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)+6 more
Similarity Score14%

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Recurrent Adult Acute Myeloid LeukemiaRecurrent Childhood Acute Myeloid LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+5 more
Similarity Score12%

Guillermo Garcia-Manero

M.D. Anderson Cancer Center

Related
9 trials

Shared therapeutic areas:

Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+4 more
Similarity Score11%

Jorge Cortes

M.D. Anderson Cancer Center

Related
8 trials

Shared therapeutic areas:

Recurrent Adult Acute Myeloid LeukemiaSecondary Acute Myeloid LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+4 more
Similarity Score11%

Roger Strair, MD, PhD

Rutgers Cancer Institute of New Jersey

Related
10 trials

Shared therapeutic areas:

Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+3 more
Similarity Score9%

Tapan M Kadia

M.D. Anderson Cancer Center

Related
13 trials

Shared therapeutic areas:

Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaSecondary Acute Myeloid Leukemia+1 more
Similarity Score6%

Neal Flomenberg, MD

Thomas Jefferson University

Related
7 trials

Shared therapeutic areas:

Recurrent Adult Acute Myeloid LeukemiaRecurrent Childhood Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia+1 more
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT03665675Early Phase 1PrincipalInvestigator

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

AdenovirusAllogeneic Hematopoietic Stem Cell Transplantation RecipientCytomegalovirus+2 more
Recruiting
NCT04220684Phase 1PrincipalInvestigator

Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML

Allogeneic Stem Cell Transplant RecipientBlasts 10 Percent or More of Bone Marrow Nucleated CellsRecurrent Acute Myeloid Leukemia+1 more
Completed
NCT03537599Phase 1/2PrincipalInvestigator

Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant

Minimal Residual DiseaseRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related ChangesRecurrent Adult Acute Myeloid Leukemia+1 more
Terminated
NCT02316964Phase 1PrincipalInvestigator

Decitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+5 more
Completed

All 4 trials loaded